Bridgebio Oncology Therapeutics, Inc. (BBOT)
7.31
-0.47
(-6.04%)
USD |
NASDAQ |
Jun 09, 16:00
7.31
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Total Assets (Quarterly) : 417.65M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Erasca, Inc. | 461.23M |
| Bicara Therapeutics, Inc. | 553.60M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.37M |
| Shareholders Equity (Quarterly) | 372.28M |
| Debt to Equity Ratio | 0.0071 |
| Current Ratio | 6.160 |
| Net Debt Paydown Yield | -0.07% |